Skip to content

Focus group research regarding medication use in asthma patients; Focusgroep onderzoek naar medicatiegebruik bij astmapatiënten

Development and validation of the Patient-Centred Asthma Management Questionnaire (PCAMQ)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28121
Enrollment
80
Registered
2018-04-10
Start date
2018-04-18
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Interventions

The objective of the Patient-Centred Asthma Management Questionnaire (PCAMQ) project is to develop the PCAMQ which measures patients’ use of reliever- and controller medication and their beliefs and p

Sponsors

Department of General Practice and Elderly Care Medicine; University Medical Center Groningen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with mild asthma aged 18 years and older; 2) Being prescribed inhalation medication; reliever and controller; 3) Adequate oral fluency in the relevant language to enable participation in the focus group or interview; 4)Willing and able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1) (co-)Diagnosis of COPD, emphysema, chronic bronchitis or any other chronic respiratory disease (e.g., bronchiectasis); 2) Use of combination inhalers (ICS + LABA in one inhaler); 3) Single maintenance and reliever therapy (SMART); 4)Documented dementia or other mental impairment such that they are unable to provide informed consent or to complete the required tasks.

Design outcomes

Primary

MeasureTime frame
This project will result in the PCAMQ.

Secondary

MeasureTime frame
Identifying the opinions and ideas of asthma patients regarding their inhaler medication.

Contacts

Public ContactJ.W.H. Kocks

Department of General Practice; University Medical Center Groningen Antonius Deusinglaan 1

j.w.h.kocks@med.umcg.nl+31 (0)50 3632971

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)